Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection by Yoshikazu Yuki, Fanglei Zuo, Shiho Kurokawa, Yohei Uchida, Shintaro Sato, Naomi Sakon, Lennart Hammarström, Hiroshi Kiyono, Harold Marcotte

Get full text

Seed Metabolome Analysis of a Transgenic Rice Line Expressing Cholera Toxin B-subunit by Takumi Ogawa, Koji Kashima, Yoshikazu Yuki, Mio Mejima, Shiho Kurokawa, Masaharu Kuroda, Atsushi Okazawa, Hiroshi Kiyono, Daisaku Ohta

Get full text

Replication of Human Sapovirus in Human-Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells by Naomi Matsumoto, Shiho Kurokawa, Shigeyuki Tamiya, Yutaka Nakamura, Naomi Sakon, Shoko Okitsu, Hiroshi Ushijima, Yoshikazu Yuki, Hiroshi Kiyono, Shintaro Sato

Get full text

MucoRice-CTB line 19A, a new marker-free transgenic rice-based cholera vaccine produced in an LED-based hydroponic system by Yoshikazu Yuki, Yoshikazu Yuki, Yoshikazu Yuki, Shiho Kurokawa, Shiho Kurokawa, Kotomi Sugiura, Kotomi Sugiura, Koji Kashima, Shinichi Maruyama, Tomoyuki Yamanoue, Tomoyuki Yamanoue, Ayaka Honma, Mio Mejima, Natsumi Takeyama, Natsumi Takeyama, Masaharu Kuroda, Hiroko Kozuka-Hata, Masaaki Oyama, Takehiro Masumura, Rika Nakahashi-Ouchida, Rika Nakahashi-Ouchida, Rika Nakahashi-Ouchida, Kohtaro Fujihashi, Kohtaro Fujihashi, Kohtaro Fujihashi, Kohtaro Fujihashi, Takashi Hiraizumi, Eiji Goto, Hiroshi Kiyono, Hiroshi Kiyono, Hiroshi Kiyono, Hiroshi Kiyono, Hiroshi Kiyono, Hiroshi Kiyono

Get full text

Cationic-nanogel nasal vaccine containing the ectodomain of RSV-small hydrophobic protein induces protective immunity in rodents by Shingo Umemoto, Rika Nakahashi-Ouchida, Yoshikazu Yuki, Shiho Kurokawa, Tomonori Machita, Yohei Uchida, Hiromi Mori, Tomoyuki Yamanoue, Takehiko Shibata, Shin-ichi Sawada, Kazuya Ishige, Takashi Hirano, Kohtaro Fujihashi, Kazunari Akiyoshi, Yosuke Kurashima, Daisuke Tokuhara, Peter B Ernst, Masashi Suzuki, Hiroshi Kiyono

Get full text

Development of Antibody-Fragment–Producing Rice for Neutralization of Human Norovirus by Ai Sasou, Yoshikazu Yuki, Yoshikazu Yuki, Shiho Kurokawa, Shintaro Sato, Shintaro Sato, Shintaro Sato, Yuki Goda, Masao Uchida, Naomi Matsumoto, Hiroshi Sagara, Yuji Watanabe, Masaharu Kuroda, Naomi Sakon, Kotomi Sugiura, Rika Nakahashi-Ouchida, Rika Nakahashi-Ouchida, Hiroshi Ushijima, Kohtaro Fujihashi, Kohtaro Fujihashi, Hiroshi Kiyono, Hiroshi Kiyono, Hiroshi Kiyono, Hiroshi Kiyono

Get full text

Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial by Yoshikazu Yuki, PhD, Masanori Nojima, MD, Osamu Hosono, MD, Hirotoshi Tanaka, ProfMD, Yasumasa Kimura, PhD, Takeshi Satoh, PhD, Seiya Imoto, ProfPhD, Satoshi Uematsu, ProfMD, Shiho Kurokawa, PhD, Koji Kashima, PhD, Mio Mejima, PhD, Rika Nakahashi-Ouchida, PhD, Yohei Uchida, MS, Takanori Marui, MS, Noritada Yoshikawa, MD, Fumitaka Nagamura, ProfMD, Kohtaro Fujihashi, ProfDDS, Hiroshi Kiyono, ProfDDS

Get full text